Shaikh, Sibhghatulla

Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 758

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies

Baig, M. H., Ahmad, K., Moon, J. S., Park, S.-Y., Ho Lim, J., Chun, H. J., Qadri, A. F., Hwang, Y. C., Jan, A. T., Ahmad, S. S., et al. (2022) · Frontiers in Physiology

Muscle Physiology and DisordersTGF-β signaling in diseases

Cited by 135

Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study

Rizvi, S., Shakil, S., Biswas, D., Shakil, S., Shaikh, S., Bagga, P., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets

Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods

Cited by 71

Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders

Shaikh, S., Rizvi, S. M. D., Shakil, S., Riyaz, S., Biswas, D., & Jahan, R. (2016) · Biotechnology and Applied Biochemistry

Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods

Cited by 70

Predictionof Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study

Shaikh, S., Rizvi, S. M., Suhail, T., Shakil, S., Abuzenadah, A., Anis, R., Naaz, D., Dallol, A., Haneef, M., Ahmad, A., et al. (2016) · CNS & Neurological Disorders - Drug Targets

Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods

Cited by 10